Pluslife is showcasing its latest molecular Point-of-Care Testing (POCT) products at the IBMS Congress 2023 on Sep 25-28, in Birmingham, UK. Visitors can find Pluslife at Booth F20 in Hall 1 Foyer and discover the cutting-edge innovations in molecular POCT diagnostic technology, featuring integrated POC molecular analyzers and solutions tailored for a variety of infections, such as respiratory infections, STIs, and pandemic pathogens.

The annual event, IBMS Congress, is hosted by the Institute of Biomedical Science (IBMS), the leading professional body for biomedical scientists with a rich history spanning over a century. As the UK's largest biomedical science exhibition featuring the leading diagnostic companies, IBMS Congress attracts over 3,000 leading experts in the field of biomedical sciences, providing them with a global platform to exchange the latest research, new technology, and industry trends. Participants can explore cutting-edge technological advancements, products, services, and equipment within the evolving field of diagnostics.

As a focal point for molecular diagnostics at the event, Pluslife offers visitors in-depth knowledge about its best-known POC molecular analyzers: Pluslife Mini Dock and Pluslife Dock Pro 8. With test results delivered 3-5 hours earlier than traditional nucleic acid testing, these analyzers provide PCR-level accurate test results within 35 mins, while maintaining the ease of use akin to antigen tests. Pluslife's molecular POCT products empower healthcare providers to efficiently prescribe targeted medication and prompt treatment in both secondary and primary care settings.

As the year-round respiratory infection season approaches and with the simultaneous presence of SARS-CoV-2, RSV, and influenza this year, Pluslife is prepared to meet the growing demand for effective differentiation between these pathogens. To address this need, Pluslife offers rapid respiratory testing solutions through single and combo test cards, such as the SARS-CoV-2/Flu A/Flu B test card and the RSV/Flu A/Flu B test card. The tests enable timely detection and distinction of these pathogens, ensuring appropriate patient treatment as well as sooner infection control.

Pluslife is excited to showcase its innovative molecular POCT technology and products at the IBMS Congress, where engaging discussions with experts and physicians from around the world have been truly inspiring. Our next exhibition is set to be Medica 2023, taking place from November 13-16 in Dusseldorf, Germany.